APC CEO Scott Brunner was a guest on “On The Pen” — a YouTube channel dedicated to all things GLP-1....
Getting away from GLP-1s, Pharmaceutical Executive features CEO Scott Brunner and Chief Advocacy Off...
Reuters, like many other media outlets, covered Novo Nordisk’s request that the FDA add semaglutide ...
A different angle: CBS News quoted Scott on the issue of how the FDA decides when a shortage is reso...
UK-based pharmaphorum is covering the GLP-1 issue on this side of the pond — specifically Lilly’s an...
The Hill covers the fallout from the FDA’s taking tirzepatide off the shortage list — especially how...
Specialty Pharmacy Continuum has a great piece explaining why a longer “tail” for 503A pharmacies wo...
Wired wrote about “The Crackdown on Compounded GLP-1 Meds,” where it made clear that it doesn’t quit...
Kudos to Wired for its piece, “A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating...
In a piece on the battle between Eli Lilly and compounding pharmacists over tirzepatide — notably th...